Stein Gold L, Bagel J, Tyring SK, Hong C- ho, Pavlovsky L, Pinter A, Reich A, Drogaris L, Wu T, Photowala H, Stakias V, Richter S, Papp K. Efficacy and Safety of Risankizumab Compared with Apremilast in Patients with Moderate Plaque Psoriasis: Mean PASI and BSA Results From the Phase 4 IMMpulse Trial. J of Skin [Internet]. 2023 Nov. 13 [cited 2024 Jul. 3];7(6):s257. Available from: https://jofskin.org/33014/index.php/skin/article/view/2404